Asia: Antisera Market 2024

Antisera Market Size in Asia

The Asian antisera market reached $X in 2022, rising by X% against the previous year. In general, consumption posted a prominent increase. The level of consumption peaked in 2022 and is likely to continue growth in the near future.

Antisera Production in Asia

In value terms, antisera production reached $X in 2022 estimated in export price. Over the period under review, production, however, showed strong growth. The growth pace was the most rapid in 2020 when the production volume increased by X%. As a result, production attained the peak level of $X. From 2021 to 2022, production growth failed to regain momentum.

Antisera Exports

Exports in Asia

In 2022, after three years of growth, there was significant decline in shipments abroad of antisera and other blood fractions, when their volume decreased by X% to X tons. In general, exports, however, continue to indicate significant growth. The pace of growth was the most pronounced in 2021 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons, and then declined remarkably in the following year.

In value terms, antisera exports contracted significantly to $X in 2022. Over the period under review, exports, however, saw a significant increase. The pace of growth appeared the most rapid in 2020 with an increase of X%. Over the period under review, the exports attained the maximum at $X in 2021, and then reduced markedly in the following year.

Exports by Country

China represented the largest exporting country with an export of around X tons, which recorded X% of total exports. Singapore (X tons) held the second position in the ranking, followed by South Korea (X tons) and Turkey (X tons). All these countries together held approx. X% share of total exports. India (X tons) held a minor share of total exports.

Exports from China increased at an average annual rate of X% from 2012 to 2022. At the same time, South Korea (X%), Turkey (X%), Singapore (X%) and India (X%) displayed positive paces of growth. Moreover, South Korea emerged as the fastest-growing exporter exported in Asia, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of South Korea and Turkey increased by X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, South Korea ($X), Singapore ($X) and China ($X) were the countries with the highest levels of exports in 2022, with a combined X% share of total exports. Turkey and India lagged somewhat behind, together accounting for a further X%.

Turkey, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the export price in Asia amounted to $X per ton, picking up by X% against the previous year. In general, the export price recorded a relatively flat trend pattern. Over the period under review, the export prices hit record highs at $X per ton in 2019; however, from 2020 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was South Korea ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Turkey (X%), while the other leaders experienced more modest paces of growth.

Antisera Imports

Imports in Asia

After ten years of growth, overseas purchases of antisera and other blood fractions decreased by X% to X tons in 2022. Overall, imports, however, enjoyed a strong increase. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. As a result, imports reached the peak of X tons, and then dropped in the following year.

In value terms, antisera imports totaled $X in 2022. In general, imports, however, showed buoyant growth. The pace of growth was the most pronounced in 2019 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum in 2022 and are likely to continue growth in the immediate term.

Imports by Country

In 2022, China (X tons), distantly followed by Taiwan (Chinese) (X tons), Singapore (X tons), Japan (X tons), Israel (X tons), the United Arab Emirates (X tons) and Turkey (X tons) represented the key importers of antisera and other blood fractions, together committing X% of total imports. The Philippines (X tons), South Korea (X tons), Iran (X tons), Malaysia (X tons), India (X tons) and Thailand (X tons) held a minor share of total imports.

From 2012 to 2022, average annual rates of growth with regard to antisera imports into China stood at X%. At the same time, the Philippines (X%), Taiwan (Chinese) (X%), the United Arab Emirates (X%), Singapore (X%), Israel (X%), Malaysia (X%), India (X%), Thailand (X%), Iran (X%), Turkey (X%) and South Korea (X%) displayed positive paces of growth. Moreover, the Philippines emerged as the fastest-growing importer imported in Asia, with a CAGR of X% from 2012-2022. Japan experienced a relatively flat trend pattern. Taiwan (Chinese) (X p.p.), Singapore (X p.p.), the United Arab Emirates (X p.p.), Israel (X p.p.) and the Philippines (X p.p.) significantly strengthened its position in terms of the total imports, while Turkey, South Korea, China and Japan saw its share reduced by X%, X%, X% and X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest antisera importing markets in Asia were Japan ($X), China ($X) and South Korea ($X), with a combined X% share of total imports. Taiwan (Chinese), Turkey, Israel, Singapore, the United Arab Emirates, India, Iran, Thailand, the Philippines and Malaysia lagged somewhat behind, together accounting for a further X%.

Among the main importing countries, the Philippines, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia stood at $X per ton in 2022, with an increase of X% against the previous year. Over the last decade, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2018 when the import price increased by X% against the previous year. Over the period under review, import prices hit record highs at $X per ton in 2019; however, from 2020 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Japan ($X,598 per ton), while the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Korea (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :